These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21950)

  • 1. Synthesis, physicochemical properties, and antitumor activities of analogs of 1-phenyl-3-benzyl-3-methyltriazenes.
    Dunn WJ; Greenberg MJ
    J Pharm Sci; 1977 Oct; 66(10):1416-9. PubMed ID: 21950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.
    Wilman DE; Goddard PM
    J Med Chem; 1980 Sep; 23(9):1052-4. PubMed ID: 7411549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cluster analysis in the development of structure-activity relations for antitumor triazenes.
    Dunn WJ; Greenberg MJ; Callejas SS
    J Med Chem; 1976 Nov; 19(11):1299-301. PubMed ID: 1003406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of aminoacid derivatives of the antimetastatic agent DM-COOK.
    Lassiani L; de Nardo MM; Nisi C; Varnavas A
    Farmaco Sci; 1988 Mar; 43(3):227-38. PubMed ID: 3417008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.
    Wilman DE; Cox PJ; Goddard PM; Hart LI; Merai K; Newell DR
    J Med Chem; 1984 Jul; 27(7):870-4. PubMed ID: 6737430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytotoxic effects of hydroxymethyl-3-pyridyl- and 2-chloro-5-pyridyltriazene derivatives.
    Grancharov KC; Koch M; Volm M; Kolar GF
    Cancer Lett; 1988 Aug; 41(3):271-9. PubMed ID: 3409206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the mode of action of antitumor triazenes and triazines. 6. 1-Aryl-3-(hydroxymethyl)-3-methyltriazenes: synthesis, chemistry, and antitumor properties.
    Vaughan K; Tang Y; Llanos G; Horton JK; Simmonds RJ; Hickman JA; Stevens MF
    J Med Chem; 1984 Mar; 27(3):357-63. PubMed ID: 6699881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, physicochemical characterization and preliminary pharmacological in vitro evaluation of two novel cytotoxic benzophenone-linked 3,3-dimethyltriazenes.
    Manolov I; Machulla HJ; Momekov G
    Pharmazie; 2006 Jun; 61(6):511-6. PubMed ID: 16826969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of methyltriazene prodrugs simultaneously releasing DNA-methylating agents and the antiresistance drug O(6)-benzylguanine.
    Wanner MJ; Koch M; Koomen GJ
    J Med Chem; 2004 Dec; 47(27):6875-83. PubMed ID: 15615536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ; Hansch C; Kim KH; Milstein SR; Schmidt CL; Smith RN; Quinn FR
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of alkyltriazenopyrazoles.
    Zakharieva RD; Spassova MK; Karaivanova MC; Golovinsky EV
    Arzneimittelforschung; 1984; 34(6):661-3. PubMed ID: 6541485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazene drug metabolites. Part 17: Synthesis and plasma hydrolysis of acyloxymethyl carbamate derivatives of antitumour triazenes.
    Carvalho E; Francisco AP; Iley J; Rosa E
    Bioorg Med Chem; 2000 Jul; 8(7):1719-25. PubMed ID: 10976519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-triazenoindoles: synthesis and biological activity.
    Barraja P; Diana P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
    Anticancer Res; 2002; 22(2A):837-40. PubMed ID: 12014660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antineoplastic agents on a 1-phenyl-3,3-dimethyltriazene base. I. Introduction].
    Matrka M; Zvĕrina V; Marhold J
    Cesk Farm; 1975 Jul; 24(6):262-6. PubMed ID: 1182834
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines.
    Lin AJ; Loo TL
    J Med Chem; 1978 Mar; 21(3):268-72. PubMed ID: 628002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and antitumour activity of 8-triazenopurines].
    Zhang WN
    Yao Xue Xue Bao; 1982 Dec; 17(12):909-16. PubMed ID: 7183123
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on antitumor agents. 8. Antitumor activities of O-alkyl derivatives of 2'-deoxy-5-(trifluoromethyl)uridine and 2'-deoxy-5-fluorouridine.
    Yamashita J; Takeda S; Matsumoto H; Unemi N; Yasumoto M
    J Med Chem; 1989 Jan; 32(1):136-9. PubMed ID: 2521251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of information content, structural information content, hydrophobicity and van der Waals volume in the design of barbiturates and tumor inhibitory triazenes. A comparative study.
    Ray SK; Basak SC; Raychaudhury C; Roy AB; Ghosh JJ
    Arzneimittelforschung; 1983; 33(3):352-6. PubMed ID: 6683508
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of 1-aryl-3-formyl-3-methyltriazenes, potential metabolites of 1-aryl-3,3-dimethyltriazenes.
    Lassiani L; Nisi C; Sigon F; Sava G; Giraldi T
    J Pharm Sci; 1980 Sep; 69(9):1098-9. PubMed ID: 7411419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.